UK Court Decides Kids under the Age of 16 Can Take Puberty Blocking Medication Without Court Approval

Bink, a gender non-conforming 10 year old child playing outside.

Doctors can now prescribe puberty blocking medication to children under the age of 16 without a judge’s approval, Britain’s Court of Appeals ruled on Friday.

The decision reverses last year’s ruling that children seeking gender reassignment aren’t mature enough to give informed consent to take puberty blocking medicine, the Associated Press reported. The decision said that doctors should seek court approval before prescribing the medication because the drugs were still experimental.

The Tavistock and Portman National Health Service (NHS) trust, Britain’s only gender identity development service (GIDS) for children, appealed last year’s ruling, the AP reported. The Court of Appeal sided with the trust Friday, ruling it was “inappropriate” for the high courts to issue their guidance, and it was up to the doctors to “exercise their judgment” regarding patients’ consent.

Read More

Report: Top Health Officials Tell White House to Pause Vaccine Booster Plan

Top U.S. health officials told the White House pandemic coordinator on Thursday to scale back the Biden administration’s plan to administer the coronavirus booster shots to individuals in September, The New York Times reported.

Dr. Janet Woodcock, the acting commissioner of the Food and Drug Administration (FDA), and Dr. Rochelle P. Walensky, the director of the Centers for Disease Control and Prevention (CDC), told White House Coronavirus Response Coordinator Jeffrey D. Zients that they need more time to collect and analyze the necessary data relating to the booster shots, The New York Times reported.

The doctors told Zients that their agencies might be able to determine whether to recommend boosters for recipients of the Pfizer-BioNTech vaccine in the coming weeks, according to the Times.

The two doctors presented their argument to Zients at a meeting on Thursday. It is unclear how Zients responded to the news.

Read More